DeepMed Research

RUSH UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1837-01-01

Employees: -

Market Cap: -

Website: https://www.rush.edu/

Clinical Trials

Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS

Phase 2

Terminated

Conditions: Myelodysplastic Syndrome

Interventions: Drug: Panhematin

First Posted Date: 2007-04-30

Last Posted Date: 2014-10-24

Lead Sponsor: Rush University Medical Center

Target Recruit Count: 6

Registration Number: NCT00467610

Locations: 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States

A Randomized Study on Comparing the Efficacy of Foley Catheter and Extraamniotic Saline Infusion for Labor Induction

Not Applicable

Completed

Conditions: Cervical Ripening
Labor, Induced

First Posted Date: 2006-08-22

Last Posted Date: 2008-01-10

Lead Sponsor: Rush University Medical Center

Target Recruit Count: 200

Registration Number: NCT00366951

Locations: 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States

Dietary Treatment of Crohn's Disease

Phase 1

Completed

Conditions: Crohn's Disease
Inflammatory Bowel Disease

Interventions: Drug: Active fructo-oligosaccharide
Drug: Placebo fructo-oligosaccharide
Dietary Supplement: Diet

First Posted Date: 2006-06-23

Last Posted Date: 2021-06-09

Lead Sponsor: Rush University Medical Center

Target Recruit Count: 73

Registration Number: NCT00343642

Locations: 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸
Gastroenterology Associates of Central Georgia, Macon, Georgia, United States

Workplace Based Rehabilitation for Low Back Disorders

Phase 3

Completed

Conditions: Low Back Pain

First Posted Date: 2006-04-20

Last Posted Date: 2023-07-11

Lead Sponsor: Rush University Medical Center

Target Recruit Count: 433

Registration Number: NCT00316342

Preliminary Study of Safety and Efficacy of Policosanol

Phase 2

Completed

Conditions: Dyslipidemia
HIV Infections

Interventions: Drug: Policosanol
Dietary Supplement: Placebo

First Posted Date: 2006-04-11

Last Posted Date: 2013-07-26

Lead Sponsor: Rush University Medical Center

Target Recruit Count: 54

Registration Number: NCT00312923

Locations: 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States

Treatment of Depression With Quetiapine

Phase 3

Terminated

Conditions: Major Depression With Psychotic Features

First Posted Date: 2005-09-15

Last Posted Date: 2008-01-10

Lead Sponsor: Rush University Medical Center

Target Recruit Count: 60

Registration Number: NCT00174603

Locations: 🇺🇸
Rush University Medical Center, Chicago,, Illinois, United States

Treatment of Major Depressive Disorder With Psychotic Features.

Phase 3

Terminated

Conditions: Major Depression With Psychotic Features

First Posted Date: 2005-09-15

Last Posted Date: 2008-01-10

Lead Sponsor: Rush University Medical Center

Target Recruit Count: 30

Registration Number: NCT00174590

Locations: 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia

Phase 2

Withdrawn

Conditions: Leukemia

First Posted Date: 2004-05-24

Last Posted Date: 2021-10-14

Lead Sponsor: Rush University Medical Center

Registration Number: NCT00003405

Locations: 🇺🇸
Rush-Riverside Cancer Center, Kankakee, Illinois, United States
🇺🇸
Cook County Hospital, Chicago, Illinois, United States
🇺🇸
Rush Cancer Institute, Chicago, Illinois, United States

and more 1 locations

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Phase 2

Withdrawn

Conditions: Drug/Agent Toxicity by Tissue/Organ
Leukemia
Myelodysplastic Syndromes
Neutropenia

Interventions: Drug: amifostine trihydrate
Drug: cytarabine
Drug: mitoxantrone hydrochloride

First Posted Date: 2004-04-27

Last Posted Date: 2023-02-02

Lead Sponsor: Rush University Medical Center

Registration Number: NCT00003407

Locations: 🇺🇸
Cook County Hospital, Chicago, Illinois, United States
🇺🇸
Angelo P. Creticos, M.D. Cancer Center, Chicago, Illinois, United States
🇺🇸
Rush Cancer Institute, Chicago, Illinois, United States

and more 1 locations

A Study of Orthotic Shoe Inserts for Controlling Osteoarthritic Knee Pain

Not Applicable

Completed

Conditions: Osteoarthritis

Interventions: Device: Lateral wedge orthotic shoe inserts
Device: Standard orthotic shoe inserts

First Posted Date: 2004-01-26

Last Posted Date: 2011-09-27

Lead Sponsor: Rush University Medical Center

Target Recruit Count: 100

Registration Number: NCT00076453

Locations: 🇺🇸
Rush University Medical Center, Section of Rheumatology, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy